About this item:

17 Views | 14 Downloads

Author Notes:

Correspondence: hyeokhyen.kwon@emory.edu

Author contributions: Conceptualization, H.K. and J.L.M.; methodology, H.K. and N.J.G.; software, H.K. and N.J.G.; validation, H.K. and N.J.G.; formal analysis, H.K., J.L.M. and N.J.G.; investigation, H.K., J.L.M. and N.J.G.; resources, S.A.F., J.L.M., G.D.C. and C.D.E.; data curation, J.L.M.; writing—original draft preparation, H.K. and N.J.G.; writing—review and editing, S.A.F., J.L.M., G.D.C. and C.D.E.; visualization, N.J.G.; supervision, H.K. and J.L.M.; project administration, H.K. and J.L.M.; funding acquisition, S.A.F., J.L.M. and G.D.C. All authors have read and agreed to the published version of the manuscript.

Competing interests: J.L.M. performs paid consulting work for Biocircuit technologies. None of these interests are directly related to the outcomes of this study. S.A.F. has the following competing interests: Honoraria: Lundbeck, Teva, Sunovion, Biogen, Acadia, Neuroderm, Acorda, CereSpire. Grants: Ipsen, Medtronics, Boston Scientific, Teva, US World Meds, Sunovion Therapeutics, Vaccinex, Voyager, Jazz Pharmaceuticals, Lilly, CHDI Foundation, Michael J. Fox Foundation, NIH. Royalties: Demos, Blackwell Futura for textbooks, Uptodate, Other Bracket Global LLC, CNS Ratings LLC. None of these interests are directly related to the outcomes of this study. C.D.E: UpToDate and Centers for Disease Control and Prevention. None of these are directly related to the outcome of the study. The other authors declare no other interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Subjects:

Research Funding:

The computational needs for this research are supported in part by Oracle Cloud credits and related resources provided by the Oracle for Research program.

This research was funded by The McCamish Center for Parkinson’s Disease Innovation, by the Curtis Family Fund, Sartain Lanier Family Foundation (S.A.F.), and NIH K25HD086276 (J.L.M.).

Keywords:

  • machine learning
  • kinematics
  • motion capture
  • Parkinson’s disease
  • motor subtypes

Classifying Tremor Dominant and Postural Instability and Gait Difficulty Subtypes of Parkinson’s Disease from Full-Body Kinematics

Tools:

Journal Title:

Sensors (Basel)

Volume:

Volume 23, Number 19

Publisher:

, Pages 8330-None

Type of Work:

Article | Final Publisher PDF

Abstract:

Characterizing motor subtypes of Parkinson’s disease (PD) is an important aspect of clinical care that is useful for prognosis and medical management. Although all PD cases involve the loss of dopaminergic neurons in the brain, individual cases may present with different combinations of motor signs, which may indicate differences in underlying pathology and potential response to treatment. However, the conventional method for distinguishing PD motor subtypes involves resource-intensive physical examination by a movement disorders specialist. Moreover, the standardized rating scales for PD rely on subjective observation, which requires specialized training and unavoidable inter-rater variability. In this work, we propose a system that uses machine learning models to automatically and objectively identify some PD motor subtypes, specifically Tremor-Dominant (TD) and Postural Instability and Gait Difficulty (PIGD), from 3D kinematic data recorded during walking tasks for patients with PD (MDS-UPDRS-III Score, 34.7 ± 10.5, average disease duration 7.5 ± 4.5 years). This study demonstrates a machine learning model utilizing kinematic data that identifies PD motor subtypes with a 79.6% F1 score (N = 55 patients with parkinsonism). This significantly outperformed a comparison model using classification based on gait features (19.8% F1 score). Variants of our model trained to individual patients achieved a 95.4% F1 score. This analysis revealed that both temporal, spectral, and statistical features from lower body movements are helpful in distinguishing motor subtypes. Automatically assessing PD motor subtypes simply from walking may reduce the time and resources required from specialists, thereby improving patient care for PD treatments. Furthermore, this system can provide objective assessments to track the changes in PD motor subtypes over time to implement and modify appropriate treatment plans for individual patients as needed.

Copyright information:

© 2023 by the authors.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote